|
Shortened Three-month DAPT Duration After PCI Demonstrates Low Rate of Adverse Events in High-Bleeding Risk Patients
|
|
Biodegradable Polymer Everolimus-eluting Stent with Shortened DAPT is Safe and Effective for PCI in Patients with Unprotected Left Main Coronary Artery Disease
|
|
Durable Polymer Drug-Eluting Stent Noninferior to a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated with One-Month DAPT
|
|
Ticagrelor Without Aspirin Three Months After Successful PCI and DAPT Reduces Major Bleeding Without Increasing the Risk of Adverse Events
|
|
TCT 2019 Career Achievement Award to be Presented to Robert O. Bonow, MD, MS
|
|
CRF Fellow Publishes Research Letter Examining Pulmonary Embolism Outcomes in JAMA
|
|
Announcing the TCT 2019 Late-Breaking Trials and Science
|
|
TCT 2019 Agenda Now Available
|
|
CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium
|
|
Late-Breaking Science Announced for TVT 2019
|
